Package 50228-521-30

{"route": ["ORAL"], "spl_id": "3d85dd4c-b57c-44f8-bb8f-c3f04545c09d", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0350228521109", "0350228521604", "0350228521307", "0350228522601", "0350228522106", "0350228522304"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["40ac26dc-2570-de7e-e063-6294a90ade72"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["ScieGen Pharmaceuticals INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (50228-521-10)", "package_ndc": "50228-521-10", "marketing_start_date": "20251009"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50228-521-30)", "package_ndc": "50228-521-30", "marketing_start_date": "20251009"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (50228-521-60)", "package_ndc": "50228-521-60", "marketing_start_date": "20251009"}], "brand_name": "ticagrelor", "product_id": "50228-521_3d85dd4c-b57c-44f8-bb8f-c3f04545c09d", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "50228-521", "generic_name": "ticagrelor", "labeler_name": "ScieGen Pharmaceuticals INC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "60 mg/1"}], "application_number": "ANDA218962", "marketing_category": "ANDA", "marketing_start_date": "20251009", "listing_expiration_date": "20261231"}